Merck KgaA Unsolicited Bid For Schering AG Would Create $13.4 Bil. Firm
This article was originally published in The Pink Sheet Daily
Executive Summary
Schering responds that Merck’s €77 per share takeover offer “undervalues” the firm and its future prospects.
You may also be interested in...
Bayer Continues Schering Takeover Bid After Rival Merck Bolsters Holdings
Merck KgaA increased its stake in Schering AG to 10.1% ahead of a June 14 deadline for shareholders to accept Bayer’s takeover offer.
Bayer Continues Schering Takeover Bid After Rival Merck Bolsters Holdings
Merck KgaA increased its stake in Schering AG to 10.1% ahead of a June 14 deadline for shareholders to accept Bayer’s takeover offer.
Bayer Purchase Of Schering AG Would Give Firm Focus On Specialty Pharma
$19. 5 bil. offer by Bayer will likely thwart hostile takeover of Schering by Merck KgaA.